Acquisitions of US Public Chem Companies Slow With Economy.(chemical companies)(Brief Article)(Statistical Data Included)

Chemical Market Reporter, April, 2001 by CHANG, JOSEPH

NO such deals announced in the last six months. WITH THE SUN setting on the first quarter of 2001, new M&A activity involving US public chemical companies has been even more conspicuously absent than positive earnings news. Coming off a robust 2000, which saw an acceleration in acquisitions of small to mid-sized public chemical companies, this part of the M&A market has hit a dry spell.

In the second and third quarters of 2000, announced acquisitions of US public chemical companies included Invitrogen/Dexter and Life Tech ($1.8 billion), Valspar/Lilly Industries ($975 million), IFF/BBA ($970 million), DSM/Catalytica Pharma ($800 million), Geon/M.A. Hanna ($570 million), Rhodia/ChiRex ($545 million), Eastman/McWhorter ($355 million) and Bayer/Sybron...

Read the rest of this article with a Free Trial at HighBeam Research.

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works.